Track topics on Twitter Track topics that are important to you
Lilly and Roche said that the Phase II/III DIAN-TU trial of their amyloid beta-targeting drugs – gantenerumab and solanezumab – failed to meet its primary endpoint in patients genetically predisposed to early-onset Alzheimer’s disease.NEXT ARTICLE
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...